Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Pfizer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Pfizer's sales performance.

Pfizer

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer Johnson &Johnson’s Zytiga (abiraterone) or Pfizer’s Xtandi (enzalutamide). ... The filing means that Rubraca has beaten rivals such as AstraZeneca/Merck &Co’s market-leading  Lynparza (olaparib), GlaxoSmithKline/Janssen’s  Zejula (niraparib)

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata Ibrance. Pfizer received a positive answer from the cost-effectiveness watchdog, with NICE approving its breast cancer drug Ibrance (palbociclib) for use on the Cancer Drugs Fund.

FDA starts speedy review of Lynparza plus Avastin in ovarian cancer

FDA starts speedy review of Lynparza plus Avastin in ovarian cancer Oncology’s Rubraca (rucaparib) and Pfizer’s Talzenna (talazoparib).

Pfizer signs $507m cancer deal with Effector Therapeutics

Pfizer signs $507m cancer deal with Effector Therapeutics Collaboration is focused on research into evasive oncogenic target. Pfizer has penned a global licensing and collaboration deal with cancer specialist Effector Therapeutics to develop small molecule eukaryotic initiation factor 4E ... It has already

FDA clears Blueprint’s $32k-per-month GI cancer drug

FDA clears Blueprint’s $32k-per-month GI cancer drug imatinib) and Pfizer’s Sutent (sunitinib), which are also available as generics, and Bayer’s Stivarga (regorafenib) which is still in patent.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The big issue
Whether you want to lead or follow, you need to understand the elephant in the C-suite...
INFOGRAPHIC 02: The Importance of clinical study websites
Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
Working with, Advocating for, and Empowering Patients
A holistic view of how to work with patients virtually...

Infographics